Phase I, Open-label Study Evaluating the Safety of Escalating Doses of Ad/PNP-F-araAMP (Ad/PNP Administered Intratumorally With Co-administration of Fludarabine Phosphate Intravenously) in Subjects With Advanced Solid Tumors.
Phase of Trial: Phase I
Latest Information Update: 19 Jun 2015
At a glance
- Drugs Purine nucleoside phosphorylase (Primary) ; Fludarabine
- Indications Solid tumours
- Focus Adverse reactions; First in man
- Sponsors PNP Therapeutics
- 17 Jun 2015 Results were published in Annals of Oncology, as per PNP Therapeutics media release.
- 02 Jun 2015 Results presented at the 51st Annual Meeting of the American Society of Clinical Oncology.
- 07 Jul 2014 Status changed from recruiting to completed as reported by ClinicalTrials.gov record.